FindTrial
Sign In

Clinical Observation and Feasibility Study on the Treatment of Axial Symptoms of Posterior Single-door Open Spinal Canal of Cervical Spondylotic Myelopathy Treated by Yishen Zhuyu Decoction

Clinical Observation and Feasibility Study on the Treatment of Axial Symptoms of Posterior Single-door Open Spinal Canal of Cervical Spondylotic Myelopathy Treated by Yishen Zhuyu Decoction

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ONR-17012963
Enrollment
Unknown
Registered
2017-10-12
Start date
2017-10-01
Completion date
Unknown
Last updated
2017-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical spondylotic myelopathy

Interventions

1:Yishenzhuyu Decoction
2:oral Celecoxib Capsules

Sponsors

Gansu Provincial Hospital of TCM
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Cervical spondylotic myelopathy in the cervical spine of the open-door thoracic surgery; (2) Between 30 and 65 years of age; (3) Patients with postoperative cervical spondylosis symptoms after 3 months; (4) Before treatment did not accept Chinese medicine treatment; (5) Willing to accept this study.

Exclusion criteria

Exclusion criteria: 1. Preceded by axial symptoms; 2. Congenital malformations of the cervical spine; 3. Cervical trauma, cancer or severe osteoporosis; 4. Combined with heart, blood vessels, liver, kidney and hematopoietic system and other serious life-threatening primary disease and mental illness; 5. Allergies and allergies to a variety of drugs; 6. Incomplete or lost followers during follow-up. Those who meet any of the above are excluded.

Design outcomes

Primary

MeasureTime frame
NDI function evaluation;—

Countries

China

Contacts

Public ContactFan chenghu

Gansu Provincial Hospital of TCM

89772841@qq.com+86 15002591562

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026